Groupama Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$551K Sell
7,973
-104
-1% -$6.93K 0.01% 306
2026
Q1
$507K Sell
8,077
-1,140
-12% -$79.4K 0.01% 297
2025
Q4
$612K Sell
9,217
-841
-8% -$54.4K 0.01% 311
2025
Q3
$4.33M Sell
10,058
-6,455
-39% -$511K 0.06% 119
2025
Q2
$5.17M Buy
16,513
+11,438
+225% +$897K 0.09% 108
2025
Q1
$344K Sell
5,075
-2,632
-34% -$215K 0.01% 368
2024
Q4
$601K Sell
7,707
-43,849
-85% -$3.25M 0.01% 321
2024
Q3
$4.89M Buy
51,556
+31,358
+155% +$2.58M 0.13% 108
2024
Q2
$2.29M Sell
20,198
-648
-3% -$81.9K 0.03% 198
2024
Q1
$3.07M Sell
20,846
-2,501
-11% -$314K 0.06% 181
2023
Q4
$2.9M Buy
+23,347
New +$2.39M 0.08% 167

Other funds holding DXCM

Groupama Asset Management's DXCM Position: Q2 2026 in Review

Groupama Asset Management reduced its DexCom (DXCM) stake by 1.3% in Q2 2026, selling an estimated $6.93K and leaving 7,973 shares worth $551K. The position accounts for 0.01% of the portfolio, ranked #306.

Groupama Asset Management first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.17M in Q2 2025. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Groupama Asset Management held 7,973 shares of DexCom worth $551K as of Q2 2026.
  • Groupama Asset Management sold 104 DexCom shares in Q2 2026, an estimated $6.93K.
  • DexCom made up 0.01% of Groupama Asset Management's portfolio in Q2 2026, its #306 holding.
  • Groupama Asset Management first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • Groupama Asset Management's DexCom position peaked at $5.17M in Q2 2025.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.